The Recall Desk
HighFDA (Devices)·Z-2324-2012·Announced 2012-09-12

RayStation Treatment Planning Software Recalled for Dose Calculation Error

RaySearch Laboratories AB is recalling RayStation software versions 2.5.0.144 and 2.5.1.89 due to a dose calculation normalization issue. No patient mistreatment has occurred.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a medical device software defect that could lead to incorrect dose calculations in radiation therapy, a high-risk scenario, but the source explicitly states that no patient mistreatment or incidents have occurred.

Plain-English summary

RaySearch Laboratories AB is recalling 19 units of RayStation Treatment Planning System software, specifically versions 2.5.0.144 and 2.5.1.89. The recall was initiated after the firm identified an issue with dose calculation normalization in unusual optimization cases. The affected software is designed for treatment planning and analysis of radiation therapy, providing set-up parameters and dose distribution estimates for intended users.

The distribution of the affected units is worldwide, including the United States (nationwide, with specific mentions of FL, MA, NJ, and NY) and Canada, Germany, the Netherlands, and Switzerland. The firm states that this problem has not caused any patient mistreatment or other incidents. However, users must be aware of this information to avoid incorrect dose calculations during treatment planning.

Intended users, who are clinically qualified radiation therapy staff, should be aware of this defect to ensure accurate treatment planning. The recall is classified as Class II by the FDA.

The recalled product

Product
Brand name: RayStation. Generic name: Treatment Planning System. Software version and build numbers are 2.5.0.144 and 2.5.1.89. Product lifetime is 5 years. RayStation is a software system designed for treatment planning and analysis of radiation therapy. The treatment pla
Affected units
19

Distribution

Distributed nationwide across the United States.

The notice also names 4 states specifically: